Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Change in Cash (2020 - 2024)

Immuneering has reported Change in Cash over the past 5 years, most recently at -$9.1 million for Q4 2024.

  • Quarterly results put Change in Cash at -$9.1 million for Q4 2024, down 4.94% from a year ago — trailing twelve months through Dec 2024 was -$23.3 million (down 75.81% YoY), and the annual figure for FY2025 was $92.5 million, up 497.66%.
  • Change in Cash for Q4 2024 was -$9.1 million at Immuneering, up from -$14.5 million in the prior quarter.
  • Over the last five years, Change in Cash for IMRX hit a ceiling of $56.7 million in Q3 2021 and a floor of -$36.0 million in Q3 2023.
  • Median Change in Cash over the past 5 years was -$3.6 million (2020), compared with a mean of $1.5 million.
  • Biggest five-year swings in Change in Cash: surged 1723.38% in 2021 and later crashed 212.31% in 2023.
  • Immuneering's Change in Cash stood at $31.5 million in 2020, then crashed by 201.74% to -$32.0 million in 2021, then skyrocketed by 88.2% to -$3.8 million in 2022, then plummeted by 128.37% to -$8.6 million in 2023, then decreased by 4.94% to -$9.1 million in 2024.
  • The last three reported values for Change in Cash were -$9.1 million (Q4 2024), -$14.5 million (Q3 2024), and -$6.6 million (Q2 2024) per Business Quant data.